[PDF] Top 20 Rev. Bras. Reumatol. vol.51 número6 en v51n6a04
Has 10000 "Rev. Bras. Reumatol. vol.51 número6 en v51n6a04" found on our website. Below are the top 20 most common "Rev. Bras. Reumatol. vol.51 número6 en v51n6a04".
Rev. Bras. Reumatol. vol.51 número6 en v51n6a04
... Brasília cohort had 50% of patients positive by use of at least one technique (CCP2, CCP3 or CCP3.1), and most of them were strongly positive with the three techniques. The positivity percentage for anti-CCP in our study ... See full document
8
Rev. Bras. Reumatol. vol.51 número5 en v51n5a11
... The author reports a case of septic arthritis due to Streptococcus bovis after several episodes of joint effusion treated with hyaluronic acid (Hylan G-F 20) and methylprednisolone a[r] ... See full document
5
Rev. Bras. Reumatol. vol.51 número5 en v51n5a02
... of 51 patients with ankylosing spondylitis randomly selected in rheumatology ...these 51 pa- tients, fi ve (10%) had persistent abnormalities (on more than one occasion) in testes performed to assess renal ... See full document
7
Rev. Bras. Reumatol. vol.51 número5 en v51n5a03
... The following characteristics were observed in our case series: most patients affected were women (2.3:1), similar clinical and laboratory characteristics and comorbidities in both ge[r] ... See full document
7
Rev. Bras. Reumatol. vol.51 número5 en v51n5a05
... Pain was found to correlate with fatigue evaluated with visual analogue scale or Multidimensional Assessment of Fatigue in patients with rheumatoid arthritis (r = 0.46; P < 0.05).. H[r] ... See full document
6
Rev. Bras. Reumatol. vol.51 número5 en v51n5a06
... menopausal Chinese women treated with estradiol derivatives, the IgG ACA levels have decreased and those of high-density lipoprotein (HDL) increased. Thus, one can speculate that the effects of estrogens on the ... See full document
5
Rev. Bras. Reumatol. vol.51 número5 en v51n5a08
... We describe the clinical manifestations and physical capacity defi cits of patients with juvenile idiopathic arthritis (JIA), juvenile dermatomyositis (JDM), juvenile systemic lupus e[r] ... See full document
8
Rev. Bras. Reumatol. vol.51 número5 en v51n5a09
... To prevent complement-mediated injury, normal cells have regulatory mechanisms constituted by proteins categorized into two major classes: soluble in biological fl uids, such as proper[r] ... See full document
9
Rev. Bras. Reumatol. vol.51 número5 en v51n5a10
... 4. Mousa A, Henderson P, Dayal R, Bernheim J, Kent KC, Faries PL. Endoluminal recanalization in a patient with phlegmasia cerulea dolens using a multimodality approach. Vascular 2005; 13(5):313-7. 5. Albino P, Gonçalves ... See full document
4
Rev. Bras. Reumatol. vol.51 número5 en v51n5a12
... 9. Mesquita ZB, Sacchetti S, Andrade OVB, Mastrocinque TH, Okuda EM, Bastos W et al. Arterite de Takayasu na infância: revisão da literatura a propósito de seis casos. J Bras Nefrol 1998; 20:263-75. 10. Brunner J, ... See full document
4
Rev. Bras. Reumatol. vol.51 número6 en v51n6a01
... The strong points of MRI are the following: capacity to directly assess bone tissue, considering that bone edema is one of the good predictors of future bone erosions; a more complete[r] ... See full document
3
Rev. Bras. Reumatol. vol.51 número4 en v51n4a01
... 5. Skare TL, Nakano I, Escuissiato DL, Batistetti, R, Rodrigues TO, Silva MB. Alterações de tomograia pulmonar de alta resolução em pacientes com artrite reumatoide e suas associações com variáveis clínicas, demográicas, ... See full document
3
Rev. Bras. Reumatol. vol.51 número4 en v51n4a02
... This study aimed at assessing the applicability of the pain assessment instruments in each of the following hospital set- tings: orthopedic emergency unit; Rheumatology outpatient clin[r] ... See full document
6
Rev. Bras. Reumatol. vol.51 número4 en v51n4a03
... 6. Reuters VS, Buescu A, Reis FA, Almeida CP, Teixeira PF, Costa AJ et al. Clinical and muscular evaluation in patients with subclinical hypothyroidism. Arq Bras Endocrinol Metabol 2006; 50(3):523-31. 7. Ranque B, ... See full document
3
Rev. Bras. Reumatol. vol.51 número4 en v51n4a04
... The study comprised SSc patients followed up at the Service of Rheumatology of the Hospital de Clínicas of the UFPR. The study inclusion period was from September 2007 to September 20[r] ... See full document
7
Rev. Bras. Reumatol. vol.51 número4 en v51n4a05
... In the sample studied, the age of RA onset ranged from 22 to 73 years (mean, 43.9 ± 11.0 years), 24/67 (35.8%) patients were smokers and ex-smokers, and 43/67 (64.1%) had no tobacco exposure. Rheumatoid nodules were ... See full document
8
Rev. Bras. Reumatol. vol.51 número4 en v51n4a07
... its own. Thus, there are two possibilities: a) the activating receptor recognizes its ligand (not generating a signal) and the inhibitory receptor does not recognize the ligand (not g[r] ... See full document
9
Rev. Bras. Reumatol. vol.51 número4 en v51n4a08
... 80 In a summary of the results of four clinical trials of strontium ranelate, three for treatment of osteoporosis 82-86 and one for prevention, 85 2 g/day of strontium ranelate result[r] ... See full document
11
Rev. Bras. Reumatol. vol.51 número4 en v51n4a09
... 11 The infl uence of a 3-month chloroquine treatment on lipid metabolism was assessed in 34 SLE patients; total cholesterol, LDL cholesterol and tri- glycerides levels were signifi ca[r] ... See full document
4
Rev. Bras. Reumatol. vol.51 número5 en v51n5a01
... "The effi cacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythe- matosus: results of a twelve-month, multicenter, exploratory, [r] ... See full document
3
temas relacionados